LEADER 00000nam 2200481 a 4500
001 AH21639735
003 StDuBDS
005 20140624042326.0
007 cr||||||||||||
008 110930s2012 enka fs 001 0 eng|d
020 9781444346930|q(e-book)
020 9781444335675|q(pbk.)
020 9781444346930|q(PDF e-book)
020 9781444346961|q(HTML e-book)
020 9781444346947|q(ePub e-book)
020 9781444346954|q(Mobipocket e-book)
040 StDuBDS|cStDuBDS|dStDuBDSZ|dUkPrAHLS
050 0 RC112|b.C626 2012
082 04 616.9|223
245 00 Communicable disease control and health protection
handbook /|cJeremy Hawker ... [et al.].
250 3rd ed.
260 Chichester :|bWiley-Blackwell,|c2012.
300 xiii, 440 p. :|bcol. ill.
500 Previous ed.: published as Communicable disease control
handbook. Blackwell Science, 2005.
505 0 Foreword. Abbreviations. Section 1: Introduction. 1.1 How
to use this book. 1.2 Basic Concepts in the Epidemiology
and Control of InfectiousDisease. 1.3 Health Protection on
-call. Section 2: Common topics. 2.1 Meningitis and
meningism. 2.2 Gastrointestinal infection. 2.3 Community
acquired pneumonia. 2.4 Rash in pregnancy. 2.5 Rash and
fever in children. 2.6 Illness in returning travellers.
2.7 Sexually Transmitted Infections. 2.8 Jaundice. 2.9
Infection in the immunocompromised. 2.10 Blood borne viral
infections. 2.11 Vaccine Queries. 2.12 Individual measures
against infections. Section 3: Diseases. 3.1 Amoebic
dysentery. 3.2 Anthrax. 3.3 Bacillus cereus. 3.4 Botulism.
3.5 Brucellosis. 3.6 Burkholderia. 3.7 Campylobacter. 3.8
Chickenpox and shingles (varicella-zoster infections). 3.9
Chikungunya. 3.10 Chlamydophila pneumoniae. 3.11
Chlamydophila psittaci. 3.12 Chlamydia trachomatis
(genital). 3.13 Cholera. 3.14 CJD and other human
transmissible spongiformencephalopathies. 3.15 Clostridium
difficile. 3.16 Clostridium perfringens. 3.17
Coxsackievirus infections. 3.18 Cryptosporidiosis. 3.19
Cyclosporiasis. 3.20 Cytomegalovirus. 3.21 Dengue fever.
3.22 Diphtheria. 3.23 Encephalitis, acute. 3.24
Enterococci, including glycopeptide-resistant
enterococci(GRE). 3.25 Epstein Barr virus. 3.26
Escherichia coli O157 (and other E. coligastroenteritis).
3.27 Giardiasis. 3.28 Gonorrhoea, syphilis and other acute
STIs. 3.29 Hantavirus. 3.30 Head lice. 3.31 Helicobacter
pylori. 3.32 Hepatitis A. 3.33 Hepatitis B. 3.34 Hepatitis
C. 3.35 Delta hepatitis. 3.36 Hepatitis E. 3.37 Herpes
simplex. 3.38 Haemophilus influenzae type b (Hib). 3.39
HIV. 3.40 Influenza. 3.41 Japanese B encephalitis. 3.42
Kawasaki Syndrome. 3.43 Legionellosis. 3.44 Leprosy. 3.45
Leptospirosis. 3.46 Listeria. 3.47 Lyme disease. 3.48
Malaria. 3.49 Measles. 3.50 Meningococcal infection. 3.51
Molluscum contagiosum. 3.52 MRSA (methicillin-resistant
Staphylococcus aureus). 3.53 Mumps. 3.54 Mycoplasma. 3.55
Norovirus. 3.56 Paratyphoid fever. 3.57 Parvovirus B19
(fifth disease). 3.58 Plague. 3.59 Pneumococcal infection.
3.60 Poliomyelitis. 3.61 Q fever. 3.62 Rabies. 3.63
Relapsing Fever. 3.64 Respiratory syncytial virus (RSV).
3.65 Ringworm. 3.66 Rotavirus. 3.67 Rubella. 3.68
Salmonellosis. 3.69 Severe Acute Respiratory Syndrome
(SARS). 3.70 Scabies 3.71 Shigella. 3.72 Smallpox. 3.73
Staphylococcal food poisoning. 3.74 Streptococcal
infections. 3.75 Tetanus. 3.76 Threadworms. 3.77 Tick-
borne encephalitis. 3.78 Toxocara. 3.79 Toxoplasmosis.
3.80 Tuberculosis. 3.81 Tularaemia. 3.82 Typhoid fever.
3.83 Rickettsial infections (incl. Typhus) Ehrlichia
andBartonella. 3.84 Vibrio parahaemolyticus. 3.85 Viral
haemorrhagic fevers. 3.86 Warts and verrucae. 3.87 West
Nile Virus. 3.88 Whooping cough. 3.89 Yellow fever. 3.90
Yersiniosis. 3.91 Other organisms. Section 4: Services and
organisations. 4.1 Surveillance of communicable disease.
4.2 Managing infectious disease incidents and outbreaks.
4.3 Infection Prevention and Control in the Community. 4.4
Healthcare Associated Infection. 4.5 Antimicrobial
Resistance. 4.6 Risks to and from Health Care Workers. 4.7
Co-ordination of immunisation services. 4.8 Services for
sexual health and HIV infection. 4.9 Services for
tuberculosis control. 4.10 Travel Health. 4.11 Pandemic
Preparedness and the Influenza A H1N1 2009Pandemic. 4.12
Non-infectious environmental hazards. 4.13 Managing acute
chemical incidents. 4.14 Managing acute radiation
incidents. 4.15 Deliberate release of biological, chemical
or radiologicalagents. 4.16 Media Relations and Crisis
Communication. 4.17 Clinical Governance and Audit. 4.18
Global health. Section 5: Communicable disease control in
Europe. 5.1 WHO and International Health Regulations
(IHR). 5.2 Collaboration within the European Union. 5.3
Detailed national example: organisational arrangements
forhealth protection: England, 2010. 5.4 Austria. 5.5
Belgium. 5.6 Bulgaria. 5.7 Cyprus. 5.8 Czech Republic. 5.9
Denmark. 5.10 Estonia. 5.11 Finland. 5.12 France. 5.13
Germany. 5.14 Greece. 5.15 Hungary. 5.16 Iceland. 5.17
Ireland. 5.18 Italy. 5.19 Latvia. 5.20 Lithuania. 5.21
Luxembourg. 5.22 Malta. 5.23 The Netherlands. 5.24 Norway.
5.25 Poland. 5.26 Portugal. 5.27 Romania. 5.28 Slovakia.
5.29 Slovenia. 5.30 Spain. 5.31 Sweden. 5.32 Switzerland.
5.33 United Kingdom. Appendix 1 Useful addresses and
telephone numbers. Appendix 2 Guidance documents and
books. Index.
506 1 400 annual accesses.|5UkHlHU
650 0 Communicable diseases.
650 0 Communicable diseases|xPrevention.
700 1 Hawker, Jeremy.
740 0 Communicable disease control handbook.
856 40 |uhttps://www.vlebooks.com/vleweb/product/
openreader?id=Hull&isbn=9781444346930|zGo to ebook
936 Askews-P-2016/17
